BetterLife Pharma Balance Sheet

Financials in millions CAD. Fiscal year is February - January.

Millions CAD. Fiscal year is Feb - Jan.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jan '26 Jan 31, 2026	Jan '25 Jan 31, 2025	Jan '24 Jan 31, 2024	Jan '23 Jan 31, 2023	Jan '22 Jan 31, 2022
Cash & Equivalents	0.01	0.01	0.04	0.01	0.17
Cash & Short-Term Investments	0.01	0.01	0.04	0.01	0.17
Cash Growth	53.67%	-78.12%	350.03%	-95.21%	12.14%
Other Receivables	0	0.01	0.04	0.02	0.32
Receivables	0	0.01	0.04	0.02	0.32
Prepaid Expenses	0.2	0.21	0.25	0.05	0.64
Total Current Assets	0.22	0.22	0.32	0.07	1.14
Property, Plant & Equipment	-	-	-	-	0.02
Total Assets	0.22	0.22	0.32	0.07	1.16
Accounts Payable	3.95	4.5	4.44	4.9	3.34
Accrued Expenses	1.32	1.07	1.6	1.39	0.14
Short-Term Debt	0.52	0.41	0.23	0.19	0.28
Current Portion of Long-Term Debt	0.36	0.87	0.25	-	-
Current Income Taxes Payable	-	-	-	-	0.16
Other Current Liabilities	0.53	0.7	0.83	0.67	0.22
Total Current Liabilities	6.68	7.54	7.35	7.15	4.14
Long-Term Debt	0.03	0.05	0.08	-	0.03
Other Long-Term Liabilities	-	-	0.59	0.46	0.86
Total Liabilities	6.71	7.59	8.02	7.61	5.04
Common Stock	81.96	79.97	78.46	76.57	75.38
Retained Earnings	-120.09	-118.6	-115.08	-112.19	-103.17
Comprehensive Income & Other	28.35	27.95	25.81	24.89	23.91
Total Common Equity	-9.78	-10.68	-10.81	-10.73	-3.88
Minority Interest	3.3	3.32	3.11	3.19	-
Shareholders' Equity	-6.49	-7.36	-7.7	-7.53	-3.88
Total Liabilities & Equity	0.22	0.22	0.32	0.07	1.16
Total Debt	0.9	1.33	0.56	0.19	0.31
Net Cash (Debt)	-0.89	-1.32	-0.52	-0.18	-0.14
Net Cash Per Share	-0.01	-0.01	-0.00	-0.00	-0.00
Filing Date Shares Outstanding	161.79	145.49	117.08	108.68	84.4
Total Common Shares Outstanding	151.9	129.57	115.83	90.1	85.24
Working Capital	-6.46	-7.31	-7.02	-7.07	-3
Book Value Per Share	-0.06	-0.08	-0.09	-0.12	-0.05
Tangible Book Value	-9.78	-10.68	-10.81	-10.73	-3.88
Tangible Book Value Per Share	-0.06	-0.08	-0.09	-0.12	-0.05
Machinery	-	-	-	-	0.04